CommercialPrior AuthMedium impact
Elective inpatient medical admissions: level of care reviews
Harvard Pilgrim Health Care·Provider Newsletter
Effective date
Apr 1, 2026
We identified it
Jun 20, 2026
Summary
Point32Health initially planned to require prior authorization for elective inpatient medical admissions (including oncology chemotherapy) for Harvard Pilgrim Commercial members starting April 1, 2026, but has now reversed this decision and will NOT be implementing these requirements.
Action Required
No action required: Point32Health has cancelled the planned prior authorization requirement for elective inpatient medical admissions. Continue following existing processes for any drugs or services that currently require prior authorization.